Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

Genomic Medicine and Statistics Programme Celebrates 100 Students at Inaugural Symposium

The Genomic Medicine and Statistics (GMS) programme celebrated a significant milestone at its inaugural symposium on Friday 5 June, marking the recruitment of 100 students since the programme was established in 2008.

Decades old puzzle solved as scientists uncover cause of inflammatory bowel disease

Researchers have identified a damaging immune response that helps explain a long-known genetic risk factor for inflammatory bowel disease, opening new possibilities for diagnosis and targeted treatment.

Professor David Church leads first trial of vaccine to prevent Lynch syndrome-associated cancers

A new Oxford-led clinical trial will test an investigational mRNA vaccine designed to help prevent cancer in people with Lynch syndrome, an inherited condition associated with a high lifetime risk of several cancers.

Katherine Bull joins £5 million multi-modal imaging programme to improve understanding of disease

Associate Professor Katherine Bull, Principal Investigator at the Centre for Human Genetics, is part of a new Wellcome-funded programme using advanced 3D imaging, spatial gene expression analysis and artificial intelligence to better understand disease.

CHG imaging specialist Katie Holden wins global scientific imaging award

Katie Holden, from the Imaging SRF led by Dr James Bancroft at the Centre for Human Genetics, has won the global prize in Evident’s 6th Annual Image of the Year competition with her image Neuronal Cosmos.

CHG Group Leader Nicholas Provine awarded Associate Professor title

We are delighted to announce that Nick Provine has been awarded the title of Associate Professor, in recognition of his outstanding contributions to science and teaching.

New findings involving Nicky Whiffin’s team on RNU4-2-associated disorders published in Nature and Nature Genetics

A major technological advance has revealed how mutations in a tiny non-coding gene can lead to multiple neurodevelopmental disorders, opening new avenues for diagnosis and research.

Dr Alexander Mentzer Named NIHR Oxford Senior Research Fellow

Dr Alexander Mentzer, Principal Investigator and Senior Clinical Researcher at the CHG, has been awarded a prestigious NIHR Oxford Senior Research Fellowship for 2026.

Professor Julian Knight appointed Associate Head of Education for the Medical Sciences Division

The Medical Sciences Division announced that Professor Julian Knight has been appointed as its new Associate Head of Division (Education).

Biomedical Research Career Week 13-17th July 2026

Ever wondered what a biomedical researcher does? Do you have a curious mind? Are you fascinated by how biology works - both inside your body and out in nature?

Oxford University to accelerate T1D research and care with £10m gift

The University of Oxford has announced a gift of £10 million from the Bukhman Foundation to support ground-breaking research into type 1 diabetes. This generous funding will establish the Bukhman Centre for Research Excellence in Type 1 Diabetes, as well as create new academic posts and scholarships, helping to accelerate progress towards better treatments and ultimately a cure.

New research reveals optimal time intervals for COVID-19 vaccine boosters

Two new papers from University of Oxford scientists have shown how the immune system reacts differently depending on the length of interval between vaccine doses.

New Podcast: Ebola virus persistence: implications for human-to-human transmission and new outbreaks

A conversation with Miles Carroll and Oliver Meek about their recent Ebola virus persistence review article.

Respiratory syncytial virus vaccine linked to reduced dementia risk

A new study, co-led by researchers at the Centre for Human Genetics, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in the following 18 months. The findings suggest a novel explanation for how vaccines produce this effect.

Three CHG Group Leaders awarded Associate Professor title

We are delighted to announce that Gavin Band, Katherine Bull and Lahiru Handunnetthi have been awarded the title of Associate Professor, in recognition of their outstanding contributions to science and teaching.

Single cell biology of coeliac disease

Research at the Centre for Human Genetics contributes to a study that identifies key immune structures in the gut that may drive coeliac disease.

Common virus may improve skin cancer treatment outcomes

May is Skin Cancer Awareness Month, and a new study with input from researchers in the CHG has revealed that a common virus may positively influence how skin cancer patients respond to current treatments.

David Church awarded a Cancer Research UK Senior Cancer Research Fellowship

David Church received a Senior Cancer Research Fellowship from the Cancer Research UK Research Careers Committee to study MHC-I and MHC-II dysregulation in colorectal & endometrial cancer.

Study finds previously unidentified genetic determinants of rare disease

A landmark study involving researchers from the Centre for Human Genetics has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.

At-home test could play key role in type-1 diabetes screening

A new home test to diagnose type-1 diabetes (T1D) is being investigated in a major UK study led by researchers at the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre and NDM's Centre for Human Genetics.

Load More